Clinical trial
Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular…
NCT00091676 · Biovest International, Industry · Unknown status
Key facts
| NCT number | NCT00091676 |
|---|---|
| Title | Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma |
| Official title | Randomized Trial of Patient-Specific Vaccination With Conjugated Follicular Lymphoma-Derived Idiotype (FNHLId1) With Local GM-CSF in First Complete Remission |
| Acronym | BiovaxID |
| Lead sponsor | Biovest International, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Hodgkins Lymphoma |
| Intervention type | Biological |
| Interventions | FNHLId1, KLH + GM-CSF |
| Enrollment | 629 |
| Start date | Jan 1, 2000 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Sep 17, 2004 |
| Last update posted | Feb 3, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: